MDxHealth SA (NASDAQ: MDXH) reported Q3 EPS of ($0.40), $0.13 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $23.3 million versus the consensus estimate of $21.44 million.

GUIDANCE:

MDxHealth SA sees FY2024 revenue of $87-89 million, versus the consensus of $83.314 million.

For earnings history and earnings-related data on MDxHealth SA (MDXH) click here.